Top Biotech. Stocks: Cadence Pharmaceuticals, Codexis, Northwest Biotherapeutics, Vanda Pharmaceuticals Inc

Lakeway, TX -- (SBWIRE) -- 02/27/2013 -- Bestdamnpennystocks, an investment community with a special focus on updating investors with recent news on the U.S. stock market, issues news alert on the following stocks:-

Cadence Pharmaceuticals, Inc.(NASDAQ:CADX) added 1.48% and is trading at $4.81. Cadence Pharmaceuticals, Inc. operates as a biopharmaceutical company. The Company focuses on the development and commercialization of therapeutics utilized primarily in the hospital setting. Cadence Pharmaceuticals' initial focus is on hospital-use anti-infectives.

How Should Investors Trade CADX After The Recent Movement? Find Out Here

Codexis, Inc.(NASDAQ:CDXS) is higher 0.47% and is trading at $2.13. Codexis, Inc. provides biocatalyst and fermentation processes and products. The Company provides its customers research and development services, biocatalysts and fermentation strains, synthetic and natural products. It is a subsidiary of publicly-traded Maxygen.

Is CDXS Strong Buy After The Recent Strong Gains? Get Free Trend Analysis Here

Northwest Biotherapeutics, Inc(NASDAQ:NWBO) added 0.40% and is trading at $3.29. Northwest Biotherapeutics, Inc. is a development-stage company. The Company focuses on discovering, developing, and commercializing immunotherapy products that generate and enhance immune system responses to treat cancer.

Is NWBO a Buying Opportunity After The Recent Plunge? Don’t Miss Out Our Latest Report Here

Vanda Pharmaceuticals Inc.(NASDAQ:VNDA) is higher 0.13% and is trading at $3.88. Vanda Pharmaceuticals Inc. (Vanda), is a biopharmaceutical company focused on the development and commercialization of products for central nervous system disorders. The Company’s products include Fanapt a compound for the treatment of schizophrenia andTasimelteon is a compound for the treatment of sleep and mood disorders, including Circadian Rhythm Sleep Disorders (CRSD).

How Should Investors Trade VNDA After The Latest Earnings Report? Find Out Here

About bestdamnpennystocks.com
Best Damn Penny Stocks’ team is engaged in providing stock newsletters on various hot penny stocks on a regular basis. Our instant stock news on Major Gainers, small cap penny stocks and various other stocks, guides investors in making the wise stock market investments decision. In order to get update to the markets, we would advise you sign up to our free newsletters. You can become leader in stock market by keeping track of the daily activity.

Disclaimer
The assembled information disseminated by Bestdamnpennystocks.com is for information purposes only, and is neither a solicitation to buy nor an offer to sell securities. Bestdamnpennystocks.com does expect that investors will buy and sell securities based on information assembled and presented in Bestdamnpennystocks.com. PLEASE always do your own due diligence, and consult your financial advisor.